Document Detail


K-ras oncogene mutations in osteoclast-like giant cell tumors of the pancreas and liver: genetic evidence to support origin from the duct epithelium.
MedLine Citation:
PMID:  9777987     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Osteoclast-like giant cell tumors (OCGTs) of the pancreas and liver are enigmatic tumors. Despite their striking morphologic resemblance to certain mesenchymal tumors of bone and tendon sheath, it has been suggested that these tumors may, in fact, arise from epithelial precursors. It is also unclear whether the osteoclast-like giant cells in OCGTs are neoplastic or nonneoplastic. We identified OCGTs of the pancreas and liver that were associated with atypical intraductal epithelial proliferations or mucinous cystic neoplasms. To determine the relationship between the noninvasive epithelial proliferations and the infiltrating OCGTs, each individual component was analyzed for mutations at codon 12 of the K-ras oncogene. Four of the five-duct epithelial lesions harbored activating mutations of the K-ras oncogene. In each case, the same K-ras mutation was also present in the mononuclear cells from the paired OCGT. Moreover, these same mutations were detected when the osteoclast-like giant cells were individually microdissected and analyzed. A panel of immunohistochemical stains was performed, and the osteoclast-like giant cells demonstrated macrophage differentiation. These cells were consistently reactive for the monocyte/macrophage marker KP1, but showed absent staining for a panel of epithelial markers. The infiltrating mononuclear cells lacked strong staining for epithelial markers and monocyte/macrophage markers. These findings suggest that OCGTs of the pancreas and liver are undifferentiated carcinomas that arise directly from intraductal epithelial precursors. The finding of K-ras mutations in the osteoclast-like giant cells may reflect their propensity to phagocytize tumor cells.
Authors:
W H Westra; P Sturm; P Drillenburg; M A Choti; D S Klimstra; J Albores-Saavedra; A Montag; G J Offerhaus; R H Hruban
Related Documents :
21509907 - Concise review: emerging concepts in clinical targeting of cancer stem cells.
6891777 - Intraarterial management of giant-cell tumors of the spine in children.
188997 - Intracisternal a and bar-shaped particles in murine neuroblastoma c 1300.
21386777 - Steroid-induced inflammatory neuropathy in a patient on tumor necrosis factor-α antagon...
15920147 - Increased expression and activity of matrix metalloproteinases characterize embolic car...
22273797 - Quantitative analysis of the growth kinetics of chemically-induced mouse liver tumors b...
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  The American journal of surgical pathology     Volume:  22     ISSN:  0147-5185     ISO Abbreviation:  Am. J. Surg. Pathol.     Publication Date:  1998 Oct 
Date Detail:
Created Date:  1998-10-28     Completed Date:  1998-10-28     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7707904     Medline TA:  Am J Surg Pathol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1247-54     Citation Subset:  IM    
Affiliation:
Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antigens, CD / metabolism
Antigens, Differentiation, Myelomonocytic / metabolism
Bile Ducts / metabolism,  pathology
DNA Primers / chemistry
DNA, Neoplasm / analysis
Epithelial Cells / metabolism,  pathology
Genes, ras / genetics*
Giant Cell Tumors / genetics*,  metabolism,  pathology
Giant Cells / metabolism,  pathology
Humans
Immunoenzyme Techniques
Liver Neoplasms / genetics*,  metabolism,  pathology
Macrophages / metabolism
Mutation*
Osteoclasts / pathology
Pancreatic Ducts / metabolism,  pathology
Pancreatic Neoplasms / genetics*,  metabolism,  pathology
Grant Support
ID/Acronym/Agency:
P50-CA62924/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Antigens, CD; 0/Antigens, Differentiation, Myelomonocytic; 0/CD68 antigen, human; 0/DNA Primers; 0/DNA, Neoplasm

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors.
Next Document:  Splenic pathology in myelodysplasia: a report of 13 cases with clinical correlation.